Pharmaceuticals Analysts discuss Aldeyra Therapeutics’ (ALDX) Reproxalap and its commercial potential in Dry Eye Disease on an Analyst/Industry conference call to be held on December 13.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener